FMR LLC

Holdings History for Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Symbol: AUTL on Nasdaq
Investment type: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
Latest Disclosed Shares Owned: 10,162,348 shares
Security Ownership %: 3.8%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

12 May 2025 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,162,348 shares of Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL). This represents 3.8% ownership of the company. This is the first filing by FMR LLC disclosing ownership of Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
FMR LLC	3.8%		$13,312,676	10,162,348			$1.31	13G/A	31 Mar 2025	12 May 2025, 10:24

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0%	$0	0	-7,105,585	-100%	$1.38	Q3 2025
30 Jun 2025	0%	-0%	$16,200,733	7,105,585	-3,056,763	-30%	$2.28	Q2 2025
31 Mar 2025	0%	-0%	$15,751,639	10,162,348	-5,469,922		$1.55	Q1 2025
31 Dec 2024	0%	-0%	$36,735,835	15,632,270	-2,141,603	-12%	$2.35	Q4 2024
30 Sep 2024	0%	+0%	$64,519,159	17,773,873	+5,478,706	+45%	$3.63	Q3 2024
30 Jun 2024	0%	+0%	$42,787,181	12,295,167	+3,278,777	+36%	$3.48	Q2 2024
31 Mar 2024	0%	+0%	$57,524,568	9,016,390	+9,014,165	+405131%	$6.38	Q1 2024
31 Dec 2023	0%	0%	$14,329	2,225	0		$6.44	Q4 2023
30 Sep 2023	0%	0%	$5,184	2,225	+1,092	+96%	$2.33	Q3 2023
30 Jun 2023	0%	0%	$2,697	1,133	0		$2.38	Q2 2023
31 Mar 2023	0%	0%	$2,085	1,133	0		$1.84	Q1 2023
31 Dec 2022	0%	-0%	$2,153	1,133	-380,185	-100%	$1.90	Q4 2022
30 Sep 2022	0%	0%	$816,000	381,318	+1,133	+0.3%	$2.14	Q3 2022
30 Jun 2022	0%	-0%	$1,076,000	380,185	-1,262,100	-77%	$2.83	Q2 2022
31 Mar 2022	0%	0%	$6,848,000	1,642,285	0		$4.17	Q1 2022
31 Dec 2021	0%	+0%	$8,523,000	1,642,285	+140,297	+9.3%	$5.19	Q4 2021
30 Sep 2021	0%	-0%	$9,838,000	1,501,988	-568,500	-27%	$6.55	Q3 2021
30 Jun 2021	0%	0%	$13,748,000	2,070,488	0		$6.64	Q2 2021
31 Mar 2021	0%	+0%	$11,864,000	2,070,488	+1,957,721	+1736%	$5.73	Q1 2021
31 Dec 2020	0%	+0%	$1,008,000	112,767	+58,773	+109%	$8.94	Q4 2020
30 Sep 2020	0%	-0%	$628,000	53,994	-34,014	-39%	$11.63	Q3 2020
30 Jun 2020	0%	-0%	$1,411,000	88,008	-124,100	-59%	$16.03	Q2 2020
31 Mar 2020	0%	0%	$1,271,000	212,108	0		$5.99	Q1 2020
31 Dec 2019	0%	-0%	$2,800,000	212,108	-99,040	-32%	$13.20	Q4 2019
30 Sep 2019	0%	-0%	$3,864,000	311,148	-62,652	-17%	$12.42	Q3 2019
30 Jun 2019	0%	+0%	$6,018,000	373,800	+373,800	NEW	$16.10	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.